Condition
Muscle, Skeletal
Total Trials
6
Recruiting
1
Active
1
Completed
5
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 5 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
6Total
Not Applicable (5)
P 1 (1)
Trial Status
Completed5
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT05556239Not ApplicableCompleted
STAY-STRONG Study of Exercise Training During Chemotherapy
NCT05710614Not ApplicableCompleted
Distinct Sources of Supplementary Protein in the Resistance Exercise Training-induced Adaptations
NCT05307367Not ApplicableRecruiting
Cancer-associated Muscle Mass - Molecular Factors and Exercise Mechanisms
NCT04201977Not ApplicableCompleted
Comparison of Different Forms of Recovery on the Functionality After Physical Exercise
NCT03570424Not ApplicableCompletedPrimary
Whey Protein Support to Metabolic and Performance Adaptations in Response HIIT
NCT02535897Phase 1CompletedPrimary
Protein Ingestion and Muscle Carnitine Uptake
Showing all 6 trials